Status
Conditions
Treatments
About
To address the existing deficiencies in the knowledge regarding liver involvement and spectrum of clinical presentation and the impact of COVID-19 infection in patients of liver disease was planned. The present study will be a hospital based and the cases of confirmed COVID-19 infection will be evaluated in relation to liver involvement irrespective of pre-existing liver disease. The primary objective was to address the clinical presentation, biochemical alteration and outcomes of COVID-19 infection in subjects with chronic hepatitis, cirrhosis in comparison to those having infection in the absence of pre-existing liver disease
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
1,000 participants in 2 patient groups
Loading...
Central trial contact
Dr Ashok Choudhary, DM
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal